The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Increasing Burden of Melanoma in the United States
Open accessAbstract
It is controversial whether worldwide increases in melanoma incidence represent a true epidemic. Dramatic increases in incidence in the setting of relatively stable mortality trends have also been attributed to expanded skin screening and detection of biologically indolent tumors with low metastatic potential. To better understand how melanoma incidence trends varied by severity at diagnosis and factors relevant to screening access, we assessed recent United States incidence and mortality trends by histologic type, tumor thickness and area-level socioeconomic status (SES). We obtained population-based data regarding diagnoses of invasive melanoma among non-hispanic whites from nearly 291 million person-years of observation by the Surveillance Epidemiology and End Results (SEER) program (1992–2004). Age-adjusted incidence and mortality rates were calculated for SEER and a subset (California) for which small-area SES measure was available. Overall, melanoma incidence increased at 3.1% (p<0.001) per year. Statistically significant rises occurred for tumors of all histologic subtypes and thicknesses, including those >4mm. Melanoma incidence rates doubled in all SES groups over a 10-year period while melanoma mortality rates did not increase significantly. We conclude that screening-associated diagnosis of thinner melanomas cannot explain the increasing rates of thicker melanomas among low SES populations with poorer access to screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Socioeconomic status and breast cancer incidence in California for different race/ethnic groups
Yost, K., Perkins, C., Cohen, R., Morris, C., & Wright, W. (2001) · Cancer Causes & Control · doi:10.1023/a:1011240019516 · Cited by 965
Korn, E. L., Liu, P.-Y., Lee, S. J., Chapman, J.-A. W., Niedzwiecki, D., Suman, V. J., Moon, J., Sondak, V. K., Atkins, M. B., Eisenhauer, E. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7837 · Cited by 705
Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth, A., Wanek, L. A., & Morton, D. L. (1995) · PubMed · Cited by 569
Effects of Health Insurance and Race on Early Detection of Cancer
Roetzheim, R. G., Pal, N., Tennant, C., Voti, L., Ayanian, J. Z., Schwabe, A., & Krischer, J. P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.16.1409 · Cited by 480
Recent Trends in Cutaneous Melanoma Incidence Among Whites in the United States
Jemal, A., Devesa, S. S., Hartge, P., & Tucker, M. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.678 · Cited by 449
de Vries, E., Bray, F. I., Coebergh, J. W. W., Parkin, D. M., & European Network of Cancer Registries (2003) · International Journal of Cancer · doi:10.1002/ijc.11360 · Cited by 378
Cited by
D'Orazio, J., Jarrett, S., Amaro-Ortiz, A., & Scott, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612222 · Cited by 1,984
Reduced melanoma after regular sunscreen use: randomized trial follow-up
Green, A. C., Williams, G. M., Logan, V., & Strutton, G. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7078 · Cited by 799
Epidemiological trends in skin cancer
Apalla, Z., Lallas, A., Sotiriou, E., Lazaridou, E., & Ioannides, D. (2017) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0702a01 · Cited by 628
Eggermont, A. M., Spatz, A., & Robert, C. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60802-8 · Cited by 548
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches
Apalla, Z., Nashan, D., Weller, R. B., & Castellsagué, X. (2017) · Dermatology and Therapy · doi:10.1007/s13555-016-0165-y · Cited by 465
The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs
Rigel, D. S., Russak, J., & Friedman, R. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20074 · Cited by 420
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
Jemal, A., Saraiya, M., Patel, P., Cherala, S. S., Barnholtz-Sloan, J., Kim, J., Wiggins, C. L., & Wingo, P. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.032 · Cited by 385
Emerging trends in the epidemiology of melanoma
Nikolaou, V., & Stratigos, A. J. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12492 · Cited by 359
Computer Aided Diagnostic Support System for Skin Cancer: A Review of Techniques and Algorithms
Masood, A., & Ali Al-Jumaily, A. (2013) · International Journal of Biomedical Imaging · doi:10.1155/2013/323268 · Cited by 347
Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment
Noonan, F. P., Zaidi, M. R., Wolnicka-Glubisz, A., Anver, M. R., Bahn, J., Wielgus, A., Cadet, J., Douki, T., Mouret, S., Tucker, M. A., et al. (2012) · Nature Communications · doi:10.1038/ncomms1893 · Cited by 331
Winer, E., Gralow, J., Diller, L., Karlan, B., Loehrer, P., Pierce, L., Demetri, G., Ganz, P., Kramer, B., Kris, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2134 · Cited by 293
The past, present, and future of cancer incidence in the United States: 1975 through 2020
Weir, H. K., Thompson, T. D., Soman, A., Møller, B., & Leadbetter, S. (2015) · Cancer · doi:10.1002/cncr.29258 · Cited by 276
Galanzha, E. I., Shashkov, E. V., Spring, P. M., Suen, J. Y., & Zharov, V. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4900 · Cited by 259
Dermatologic Health Disparities
Buster, K. J., Stevens, E. I., & Elmets, C. A. (2012) · Dermatologic Clinics · doi:10.1016/j.det.2011.08.002 · Cited by 244
Teledermatology for diagnosing skin cancer in adults.
Chuchu, N., Dinnes, J., Takwoingi, Y., Matin, R. N., Bayliss, S. E., Davenport, C., Moreau, J. F., Bassett, O., Godfrey, K., O'Sullivan, C., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013193 · Cited by 175
Accuracy of teledermatology for pigmented neoplasms
Warshaw, E. M., Lederle, F. A., Grill, J. P., Gravely, A. A., Bangerter, A. K., Fortier, L. A., Bohjanen, K. A., Chen, K., Lee, P. K., Rabinovitz, H. S., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.04.032 · Cited by 175
Skin cancer risk perceptions: A comparison across ethnicity, age, education, gender, and income
Buster, K. J., You, Z., Fouad, M., & Elmets, C. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.05.021 · Cited by 148
“Age above 65 years portends greater overall MM risk and greater risk of an invasive tumor.(14,19,29) Older age is strongly associated with thicker MM(34) and poorer outcomes.”
BackgroundInfluentialSmartphone applications for triaging adults with skin lesions that are suspicious for melanoma
Chuchu, N., Takwoingi, Y., Dinnes, J., Matin, R. N., Bassett, O., Moreau, J. F., Bayliss, S. E., Davenport, C., Godfrey, K., O'Connell, S., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013192 · Cited by 144
Abdel-Malek, Z. A., Kadekaro, A. L., & Swope, V. B. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00679.x · Cited by 134
Kadekaro, A. L., Leachman, S., Kavanagh, R. J., Swope, V., Cassidy, P., Supp, D., Sartor, M., Schwemberger, S., Babcock, G., Wakamatsu, K., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-158485 · Cited by 130
Higdon, C. W., Mitra, R. D., & Johnson, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067801 · Cited by 125
Petrelli, N. J., Winer, E. P., Brahmer, J., Dubey, S., Smith, S., Thomas, C., Vahdat, L. T., Obel, J., Vogelzang, N., Markman, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6171 · Cited by 121
Tang, J. Y., Fu, T., LeBlanc, E., Manson, J. E., Feldman, D., Linos, E., Vitolins, M. Z., Zeitouni, N. C., Larson, J., & Stefanick, M. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.5967 · Cited by 117
Self-citationAssociation of Increased Dermatologist Density With Lower Melanoma Mortality
Aneja, S. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2011.345 · Cited by 114
Linos, E., Keiser, E., Fu, T., Colditz, G., Chen, S., & Tang, J. Y. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9780-1 · Cited by 97
Self-citationRobinson, J. K., Joshi, K. M., Ortiz, S., & Kundu, R. V. (2011) · Psycho-Oncology · doi:10.1002/pon.1736 · Cited by 80
“8% annual increase in the thickest cancers (Breslow depth 44mm), which have the least favorable prognosis [1].”
BackgroundClinical protein science in translational medicine targeting malignant melanoma
Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., et al. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09468-6 · Cited by 45
Vitamin D status and risk for malignant cutaneous melanoma: recent advances
Ombra, M. N., Paliogiannis, P., Doneddu, V., Sini, M. C., Colombino, M., Rozzo, C., Stanganelli, I., Tanda, F., Cossu, A., & Palmieri, G. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000334 · Cited by 39
Survival Is Not the Only Valuable End Point in Melanoma Screening
Curiel-Lewandrowski, C., Kim, C. C., Swetter, S. M., Chen, S. C., Halpern, A. C., Kirkwood, J. M., Leachman, S. A., Marghoob, A. A., Ming, M. E., & Grichnik, J. M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.3 · Cited by 26
Self-citationSinghal, S. S., Figarola, J., Singhal, J., Leake, K., Nagaprashantha, L., Lincoln, C., Gabriel Gugiu, B., Horne, D., Jove, R., Awasthi, S., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.020 · Cited by 20
Computer-Aided Assessment of Melanocytic Lesions by Means of a Mitosis Algorithm
Sturm, B., Creytens, D., Smits, J., Ooms, A. H. A. G., Eijken, E., Kurpershoek, E., Küsters-Vandevelde, H. V. N., Wauters, C., Blokx, W. A. M., & van der Laak, J. A. W. M. (2022) · Diagnostics · doi:10.3390/diagnostics12020436 · Cited by 13
Metadata
- Authors
- Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A., & Clarke, C. A.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 129
- Issue
- 7
- Pages
- 1666-1674
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2124896191
- Cited by
- 746
- References
- 37
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.